Table format of the state of the landscape For interest in a table format. Enrique, Eog and others feel free to correct the error as I'm sure there are some.
| Drug | FDA status | 3 M CR | 12 M CR | Route of administration | Number of treatments |
| Vicinium | FDA rejected | 42% | 17% | bladder instillation | 36 instills per year |
| Keytrude | Approved | 41% | 19% | intravenous | every 3 weeks (indefinitely?) |
| Atezolizumab | Likely stalled | 43% | 20% | bladder instillation | every 3 week for 1 yr |
| Adstiladrin | Approved | 53% | 24% | bladder instillation | every 3 months for first year then after (?) |
| Oportuzumab monatox | not-approved | 40% | 17% | intravenous | 15 treatment in a year approx but varies |
| n-803 + BCG | Approval deferred for now | 55% | 44% | bladder instillation | 15 treatment in a year approx but varies |
| Valrubicin | Approved but not used (?) | 21% | 8% | bladder instillation | 6 weekly as induction and that is all |
| | | | | | |
| Ruvidar | Phase 2 ongoing | 66% | 36% | bladder instillation | 2 total |